SCNI

Conviction 67HealthcareScan · Tue, Sep 8, 2026

SCNI$1.73-6.99%

ResistanceSupportVol 14

Vol MA14 454.42K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Scinai Immunotherapeutics Ltd.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.scinai.com ↗

Price1.73

Change-6.99%

Gap-3.76%

Rel volume0.07×

Avg volume348.48K

Avg $ vol430.4K

SMA 201.61

SMA 500.7964

SMA 2000.7310

Price vs 50+117.22%

Price vs 200+136.66%

MA stackbullish

50/200 crossgolden · 2d

Supertrenddown · 2.68

RSI (14)55

MACD hist-0.07

MACD crossbear · 1d

Stoch %K / %D45 / 48

ADX (14)40

+DI / −DI38 / 25

RSI divergence—

MACD divergence—

ATR %+16.17%

ADR %11.50%

52w high3.22

52w low0.2282

From 52w high-46.27%

Above 52w low+658.11%

New 52w highNo

SqueezeOff

Bollinger width289.89%

%B0.53

Donchian pos44.94%

Donchian high3.58

Donchian low0.2202

AVWAP (52w high)2.54

vs AVWAP high-31.96%

AVWAP (52w low)0.6553

vs AVWAP low+164.01%

OBV trendUp

Chaikin MF (20)-0.04

Today vs 20d0.07×

Avg vol (14d)454.42K

Avg vol (20d)348.48K

Avg $ vol (20d)430.4K

Market cap24B

RS 3m (vs SPY)+346.70%

RS 6m (vs SPY)+123.91%

RS line new highNo

Trend template5/8

Technical rank91.8

1 week-30.80%

1 month+605.26%

3 months+324.44%

6 months+133.53%

1 year+15.33%

YTD+137.15%

P/E-4140.81

P/B-4989.63

P/S—

P/FCF-2962.61

EPS-0.0100

Div yield—

ROE120.50%

ROA-24.88%

Debt/Eq-0.08

Current4.28

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth29.37%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value23.99B

Revenue—

Net income-3.52M

Gross profit—

Free cash flow-8.1M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out3.96M

Employees45

ListedTue, May 12, 2015

Free float9.65M

Float %0.1%

Short interest70.26K

Days to cover0.1d

Short volume23.3%

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank91.8 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.98

Support0.2177

Days since event—

Candle confirm—

News sentiment—

Financials as of Fri, Mar 31, 2023 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCNI

All disclosures →

No recent disclosed trades by Congress in SCNI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCNI · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Reichman Amir Chief Executive Officer · Ordinary Shares · 2026-06-16	Grant	400M	—	2026-06-16	2026-06-18
GERMAIN MARK Director · Ordinary Shares · 2026-06-16	Grant	120M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SCNI · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.